THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Income Tax Expense (Benefit) in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Therapeutic Solutions International, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2022 to Q2 2024.
  • Therapeutic Solutions International, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $800.000, unchanged year-over-year.
  • Therapeutic Solutions International, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.25K, a 40.6% increase from 2022.
  • Therapeutic Solutions International, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.6K, a 100% increase from 2021.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $800 $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q2 2023 $800 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q3 2022 $800 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.